BNP Paribas Financial Markets
NAUT icon

BNP Paribas Financial Markets’s Nautilus Biotechnolgy NAUT Stock Holding History

BNP Paribas Financial Markets’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Sell
11,494
-1,878
-14% -$4.96K ﹤0.01% 5235
2026
Q1 		$51.9K Sell
13,372
-14,339
-52% -$35.2K ﹤0.01% 4678
2025
Q4 		$54K Buy
27,711
+26,246
+1,792% +$43K ﹤0.01% 4649
2025
Q3 		$1.24K Sell
1,465
-1,963
-57% -$1.44K ﹤0.01% 5217
2025
Q2 		$2.48K Sell
3,428
-29
-0.8% -$22 ﹤0.01% 5035
2025
Q1 		$2.98K Sell
3,457
-3,793
-52% -$5.64K ﹤0.01% 4929
2024
Q4 		$12.2K Buy
+7,250
New +$17.3K ﹤0.01% 4818

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BNP Paribas Financial Markets's NAUT Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Nautilus Biotechnolgy (NAUT) stake by 14% in Q2 2026, selling an estimated $4.96K and leaving 11,494 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5235.

BNP Paribas Financial Markets first reported a position in NAUT in Q4 2024 and has held it in 7 quarters since. The position peaked at $54K in Q4 2025. 86 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • BNP Paribas Financial Markets held 11,494 shares of Nautilus Biotechnolgy worth $21.5K as of Q2 2026.
  • BNP Paribas Financial Markets sold 1,878 Nautilus Biotechnolgy shares in Q2 2026, an estimated $4.96K.
  • Nautilus Biotechnolgy made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5235 holding.
  • BNP Paribas Financial Markets first reported a position in Nautilus Biotechnolgy in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Nautilus Biotechnolgy position peaked at $54K in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.